Introduction
Nonspecific interstitial pneumonia (NSIP) is a type of interstitial lung disease (ILD) characterized by a histopathologic pattern with temporal uniformity and inflammation that may involve fibrosis including infiltrate of mixed lymphocytes and plasma cells. On radiologic imaging, findings are predominant in the bases with ground glass that may be diffuse or peripheral and rare honeycombing. It is typically responsive to corticosteroid therapy and usually carries a relatively good prognosis [1] . In the general population, NSIP has a prevalence of about 1 to 9 out of every 100,000 people with higher rates in women and the 40-50-year-old age group [1, 2] . NSIP has been associated with underlying connective tissue disease, drug-induced lung disease, and hypersensitivity pneumonia, among other etiologies including HIV which was first described in 1988 [3] . HIV is thought to lead to NSIP by way of immune dysregulation, and thus, with the advent of HAART therapy, the prevalence of HIV-associated NSIP has declined significantly [2, 3] . HIV-associated NSIP has a selfresolving course and clinical deterioration is often due to opportunistic infections [3] . Notably, NSIP and Pneumocystis pneumonia (PJP) can present similarly making accurate diagnosis more difficult, especially when the patient is too ill to safely undergo bronchoscopy [4] . Progressive NSIP can lead to rapid deterioration, requiring salvage therapies and in severe cases lung transplantation. Lung transplantation in HIVpositive patients has been successful in a small number of carefully selected patients with undetectable disease managed on HAART therapy [5] . Thus, early diagnosis of HIV and early treatment is paramount.
Case
We present a case of a 52-year-old male former smoker with a history of stable ankylosing spondylitis and recent diagnosis of NSIP. His initial complaints began 5 months prior to hospitalization at our institution with productive cough and progressive dyspnea. His primary care physician treated him for viral bronchitis with an albuterol inhaler and prednisone. The following week, our patient presented to the local emergency department with worsening dyspnea and was admitted for acute hypoxic respiratory failure managed with high flow oxygen via nasal cannula, steroids, and antibiotics. A chest CT during hospitalization showed evidence of an underlying chronic lung disease, which was read as likely a combination of moderate to severe emphysema and interstitial lung disease. A VATS lung biopsy was obtained with pathology showing cellular and fibrosing nonspecific interstitial pneumonitis. After a 3-week hospital course he was discharged, on 2 L supplemental oxygen, a steroid taper, and given follow-up with a pulmonologist. A focused history revealed no highrisk behaviors, connective tissue serologies were negative, and routine pulmonary function testing revealed borderline hypoxia with restriction physiology and severely decreased DLCO. Patient was then ordered a repeat CT chest that was never obtained. The following month, our patient returned to his local emergency department with severe dyspnea. A repeat CT chest then showed interval improvement of dense bilateral lower posterior lung infiltrates but more prominent ground glass opacification in the upper lobes. He was treated for an NSIP flare with high-dose steroids, nebulized bronchodilators, and empiric antibiotics. After 10 days without clinical improvement he was transferred to our facility for further management and urgent transplant evaluation. His oxygen requirement increased requiring bilevel positive airway pressure (BiPAP) with 100% supplemental oxygen and monitoring in the medical respiratory ICU. A high-resolution CT scan exhibited diffuse interstitial fibrosis and ground glass opacities suggestive of an ILD exacerbation. As part of his transplant evaluation, an HIV test was found to be positive with RNA viral load of 20,000 and CD4 count of 2. The patient was started on empiric PJP treatment as diagnostic bronchoscopy was deemed too high risk. Later a B-D-glucan test would return positive helping to confirm our clinical suspicion. Lung transplantation was no longer offered and the patient would later succumb to progressive respiratory failure.
Discussion
This case describes a patient with new onset of rapidly progressive NSIP resulting from previously undiagnosed HIV/ AIDS. There are two primary areas for discussion. First, because NSIP may be the first sign of HIV [4] , when assessing for etiology, in addition to other routine testing, patients may benefit from HIV testing at the time of NSIP diagnosis. The United States Preventive Services Task Force currently recommends screening all patients age 15-65 for HIV at least once and screening patients at risk multiple times as needed [6] . Our patient reported a previous negative HIV test and denied any risk factors or high-risk behaviors warranting further HIV screening by USPSTF guidelines. No alternative cause of our patient's NSIP was determined, and given his elevated viral load and near obsolete CD4 count, this was likely the mechanism. When evaluating a patient with newly diagnosed NSIP, one must consider undiagnosed HIV regardless of risk factors. This has been suggested in the past by the American Thoracic Society in 2002 guidelines on idiopathic interstitial pneumonias but was not clearly recommended [7] . In more recent guidelines from 2018, in a discussion of investigating ILD with unknown etiology, HIV was not mentioned [8] . Nonetheless, HIV testing is an essential part of the evaluation for patients with NSIP or other forms of ILD without a clear etiology. What makes this case interesting is that our patient responded well to steroids upon his initial diagnosis of NSIP which is not typical of HIV-associated NSIP cases. The proposed mechanism of HIV-associated NSIP involves a disordered immune response to HIV itself, hence why the lymphocytic alveolitis regressed with institution of ART, and why the prevalence of HIV-associated NSIP has declined with ART. Second, HIV testing would benefit newly diagnosed NSIP patients by allowing for early intervention that could prevent decline from opportunistic infections. The timing with which our patient developed PJP is unclear, but his second episode of hypoxemic respiratory failure was likely due to PJP. An earlier diagnosis of HIV would have led to PJP prophylaxis, potentially preventing this outcome [9] . We present a case of newly diagnosed HIV heralded by acute NSIP which resolved with corticosteroid therapy alone and was later complicated by PJP, suggesting that HIV screening be implemented for all new cases of undifferentiated NSIP.
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